| 肝动脉化疗栓塞联合无水乙醇注射治疗中晚期肝癌的临床分析 |
| |
| 引用本文： | 裴生俭,孙康,李卫东,张金水. 肝动脉化疗栓塞联合无水乙醇注射治疗中晚期肝癌的临床分析[J]. 肿瘤基础与临床, 2007, 20(6): 530-531 |
| |
| 作者姓名： | 裴生俭 孙康 李卫东 张金水 |
| |
| 作者单位： | 淄博市周村区人民医院,山东,淄博,255300;淄博市周村区人民医院,山东,淄博,255300;淄博市周村区人民医院,山东,淄博,255300;淄博市周村区人民医院,山东,淄博,255300 |
| |
| 摘 要： | 目的观察肝动脉化疗栓塞联合无水乙醇注射治疗中晚期肝癌的疗效。方法对23例中、晚期肝癌均先采用肝动脉化疗栓塞术，木后1—2周在CT引导下经皮肝穿刺瘤内注射无水乙醇2—5次。结果肿瘤体积缩小50％以上占30．4％（7／23），小于50％占47．8％（11／23）。AFP降至正常占34．8％（8／23），下降占52．2％（12／23）。1、2、3年生存率分别为69．6％（16／23）、52．2％（12／23）、21．7％（5／23）。结论肝动脉化疗栓塞联合无水乙醇注射是治疗中晚期肝癌的一种安全有效的综合治疗方法。
|
| 关 键 词： | 中晚期肝癌 肝动脉化疗栓塞 无水乙醇注射 |
| 文章编号： | 1673-5412（2007）06-0530-02 |
| 收稿时间： | 2007-06-27 |
| 修稿时间： | 2007-06-27 |
The Clinical Analysis of Chemoembolization and Percutaneous Ethanol Injection in Treatment of Moderate or Advanced Liver Cancer |
| |
| Pei Shengjian, Sun Kang, Li Weidong, Zhang Jinshui. The Clinical Analysis of Chemoembolization and Percutaneous Ethanol Injection in Treatment of Moderate or Advanced Liver Cancer[J]. Journal of Basic and Clinical Oncology, 2007, 20(6): 530-531 |
| |
| Authors: | Pei Shengjian Sun Kang Li Weidong Zhang Jinshui |
| |
| Abstract: | Objective To observe the clinical therapeutic effect of transcatheter arterial chemoembolization(TACE) and percutaneous ethanol injection(PEI) in moderate or advanced liver cancer.Methods For twenty-three cases with moderate or advanced liver cancer,transcatheter arterial chemoembolization was used,and after 1-2 weeks,percutaneous ethanol injection was done for 2-5 times by CT.Results 7 cases(30.4%) showed atrophy>50%,11 cases(47.8%) showed atrophy<50%;AFP returned to normal in 8 cases,and in 12 cases(52.2%) AFP decreased remarkably.The 1-,2-,3-year survival rates were 69.6%(16/23),52.2%(12/23),21.7%(5/23).Conclusions Moderate or advanced liver cancer treated with TACE PEI is a safe and efficient method. |
| |
| Keywords: | moderate or advanced liver cancer transcatheter arterial chemoembolization percutaneous ethanol injection |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
